Carlos A Zarate

Carlos A ZarateDr. Zarate completed his residency training in psychiatry at the Massachusetts Mental Health Center/Brockton VAMC division. He later completed a fellowship in Clinical Psychopharmacology at McLean Hospital of the Consolidated Department of Psychiatry Harvard Medical School and remained on staff at McLean Hospital as the Director of the Bipolar and Psychotic Disorders Outpatient Services. From 1998 to 2000 Dr. Zarate was the Chief of the Bipolar and Psychotic Disorders Program at the University of Massachusetts Medical School. In 2001, he joined the Mood and Anxiety Disorders Program at NIMH. His achievements and awards include the Ethel-DuPont Warren Award and Livingston Awards, Consolidated Department of Psychiatry, Harvard Medical School; Outstanding Psychiatrist Research Award, Massachusetts Psychiatric Association; Program for Minority Research Training in Psychiatry, APA; the National Alliance for Research on Schizophrenia and Depression Young Investigator Award; National Alliance for Research on Schizophrenia and Depression Independent Investigator Award; the National Institutes of Health Director's Award Scientific/Medical, the 2011 Brain & Behavior Research Foundation Award for Bipolar Mood Disorder Research, the 2013 National Institute of Health Director's Award--Scientific/Medical Achievement and Mogens Schou Research Award: Bipolar Disorder and the Simon-Bolivar Award American Psychiatric Association; 2015 Ruth L. Kirschtein Mentoring Award NIH and the Astute Clinician Lecture Award, NIH; the 2019 ACNP Dolores Shockley Minority Mentoring Award; and in 2019 was promoted to NIH Distinguished Investigator, NIMH, NIH. Dr. Zarate is a fellow of the American College of Neuropsychopharmacology and member of the Society of Biological Psychiatry and the Society for Neuroscience. Dr. Zarate's research focuses on the pathophysiology and development of novel therapeutics for treatment-resistant mood disorders as well as the study of biomarkers and neural correlates of treatment response. Read More Read Less

28 results found
List viewGrid view
Sort By:
1.
Ketamine for Treatment-Resistant Depression21 %
Publisher: Adis
No Review Yet
₹8,640
₹6,826
Binding:
Paperback
Release:
07 Jul 2018
Language:
English
Available
Ships within 12-14 Days Explain..
2.
Ketamine for Treatment-Resistant Depression21 %
Publisher: Adis
No Review Yet
₹10,560
₹8,342
Binding:
Hardback
Release:
15 Dec 2016
Language:
English
Available
Ships within 12-14 Days Explain..
3.
Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy37 %
Available
Ships within 12-14 Days Explain..
4.
Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy37 %
Available
Ships within 12-14 Days Explain..
5.
Behavioral Neurobiology of Bipolar Disorder and Its Treatment37 %
Available
Ships within 12-14 Days Explain..
7.
Fake news y la ciberguerra contra la #4T10 % NR
No Review Yet
₹1,342
₹1,208
Binding:
Paperback
Release:
25 Mar 2024
Language:
Spanish
International Edition
Ships within 12-14 Days Explain..
Free Shipping in India and low cost Worldwide.
18.
Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis and Pharmacotherapy59 %
Out of Stock
Notify me when this book is in stockNotify Me
19.
Ação, articulação e legalidade dos contratos públicos5 % NR
No Review Yet
₹3,612
₹3,431
Binding:
Paperback
Release:
04 Dec 2023
Language:
Portuguese
Out of Stock
Notify me when this book is in stockNotify Me
20.
Maßnahmen, Verknüpfung und Rechtmäßigkeit des staatlichen Beschaffungswesens5 % NR
No Review Yet
₹3,612
₹3,431
Binding:
Paperback
Release:
04 Dec 2023
Language:
German
Out of Stock
Notify me when this book is in stockNotify Me
loadingLoading more results